| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |